risedronic acid has been researched along with Disease Exacerbation in 11 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intravenous pamidronate is efficacious and has long been available, but its use is hindered by an impractical recommended dosing regimen of 30 mg IV over 4 h for three consecutive days." | 2.44 | A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. ( Abelson, A, 2008) |
| "Osteoporosis is widely prevalent in India and osteoporotic fractures are a common cause of morbidity and mortality." | 1.35 | Osteoporotic fracture management in India: a survey of orthopaedic surgeons. ( Lakhotia, SM, 2008) |
| " The purpose was to determine the effects of the anti-resorptive agents alone and in combination with intermittent PTH on bone formation in the mandible and a long bone in the aged ovariectomized (Ovx) rat." | 1.31 | Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone. ( Hunziker, J; Miller, SC; Wronski, TJ, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lakhotia, SM | 1 |
| Bartlett, SJ | 1 |
| Ling, SM | 1 |
| Mayo, NE | 1 |
| Scott, SC | 1 |
| Bingham, CO | 4 |
| Torregrosa, JV | 1 |
| Durán, CE | 1 |
| Barros, X | 1 |
| Blasco, M | 1 |
| Arias, M | 1 |
| Cases, A | 1 |
| Campistol, JM | 1 |
| Meulenbeld, HJ | 1 |
| van Werkhoven, ED | 1 |
| Coenen, JL | 1 |
| Creemers, GJ | 1 |
| Loosveld, OJ | 1 |
| de Jong, PC | 1 |
| Ten Tije, AJ | 1 |
| Fosså, SD | 1 |
| Polee, M | 1 |
| Gerritsen, W | 1 |
| Dalesio, O | 1 |
| de Wit, R | 1 |
| Rendina, D | 1 |
| De Filippo, G | 1 |
| Mossetti, G | 1 |
| Buckland-Wright, JC | 2 |
| Messent, EA | 1 |
| Ward, RJ | 1 |
| Tonkin, C | 1 |
| Garnero, P | 2 |
| Cohen, SB | 2 |
| Dougados, M | 1 |
| Adami, S | 1 |
| Clauw, DJ | 1 |
| Spector, TD | 1 |
| Pelletier, JP | 2 |
| Raynauld, JP | 2 |
| Strand, V | 1 |
| Simon, LS | 1 |
| Meyer, JM | 3 |
| Cline, GA | 3 |
| Beary, JF | 3 |
| Martel-Pelletier, J | 1 |
| Berthiaume, MJ | 1 |
| Abram, F | 1 |
| Choquette, D | 1 |
| Haraoui, B | 1 |
| Aronstein, WS | 1 |
| Conaghan, PG | 1 |
| Christiansen, C | 1 |
| Abelson, A | 1 |
| Hunziker, J | 1 |
| Wronski, TJ | 1 |
| Miller, SC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Placebo Controlled Trial Testing The Effect of Zoledronic Acid on Hip Osteoarthritis[NCT04303026] | Phase 3 | 70 participants (Anticipated) | Interventional | 2020-03-02 | Recruiting | ||
| Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention[NCT05204836] | Phase 1 | 56 participants (Anticipated) | Interventional | 2023-05-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for risedronic acid and Disease Exacerbation
| Article | Year |
|---|---|
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Etidronic Acid; Humans; | 2008 |
6 trials available for risedronic acid and Disease Exacerbation
4 other studies available for risedronic acid and Disease Exacerbation
| Article | Year |
|---|---|
Osteoporotic fracture management in India: a survey of orthopaedic surgeons.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Etidronic Acid; | 2008 |
Paget's disease and bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Diphosphonates; Disease Progression; Etidronic Acid; Hum | 2005 |
Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period.
Topics: Analysis of Variance; Bone and Bones; Bone Cysts; Cartilage, Articular; Diphosphonates; Disease Prog | 2008 |
Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.
Topics: Analysis of Variance; Animals; Bone Resorption; Calcitonin; Calcium Channel Blockers; Diphosphonates | 2000 |